K
Kato Daisuke
Publications - 26
Citations - 163
Kato Daisuke is an academic researcher. The author has contributed to research in topics: Reagent & Analyte. The author has an hindex of 5, co-authored 26 publications receiving 79 citations.
Papers
More filters
Journal ArticleDOI
The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan.
Yuto Takeuchi,Yusaku Akashi,Kato Daisuke,Miwa Kuwahara,Shino Muramatsu,Atsuo Ueda,Shigeyuki Notake,Koji Nakamura,Hiroichi Ishikawa,Hiromichi Suzuki +9 more
TL;DR: In this article, the analytical and clinical performance of QuickNavi™-COVID19 Ag, a newly developed antigen test in Japan, was evaluated using a prospective observational study at a PCR center between October 7 and December 5, 2020.
Journal ArticleDOI
Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study.
Yuto Takeuchi,Yusaku Akashi,Kato Daisuke,Miwa Kuwahara,Shino Muramatsu,Atsuo Ueda,Shigeyuki Notake,Koji Nakamura,Hiroichi Ishikawa,Hiromichi Suzuki +9 more
TL;DR: In this paper, a prospective study in a drive-through testing site located at a PCR center was conducted to evaluate the diagnostic performance of the antigen test QuickNavi-COVID19 Ag using anterior nasal samples and to compare the degrees of coughs or sneezes induction and the severity of pain between anterior nasal collection and nasopharyngeal collection.
Journal ArticleDOI
Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses.
Reiko Yoshida,Shino Muramatsu,Hiroshi Akita,Saito Yuji,Miwa Kuwahara,Kato Daisuke,Katendi Changula,Hiroko Miyamoto,Masahiro Kajihara,Rashid Manzoor,Wakako Furuyama,Andrea Marzi,Heinz Feldmann,Aaron S. Mweene,Justin Masumu,Jimmy Kapeteshi,Jean-Jacques Muyembe-Tamfum,Ayato Takada +17 more
TL;DR: The monoclonal antibodies specific to the ebolavirus nucleoprotein were used to develop an immunochromatography (IC) assay (QuickNavi-Ebola) for rapid diagnosis of EVD and it was confirmed that the assay could detect the viral antigen shortly after disease onset.
Journal ArticleDOI
Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals.
Yoshihiko Kiyasu,Yuto Takeuchi,Yusaku Akashi,Kato Daisuke,Miwa Kuwahara,Shino Muramatsu,Shigeyuki Notake,Atsuo Ueda,Koji Nakamura,Hiroichi Ishikawa,Hiromichi Suzuki +10 more
TL;DR: The QuickNavi™-COVID19 Ag showed lower sensitivity for the asymptomatic group than for symptomatic patients as mentioned in this paper, but its specificity was consistently high, and no false positives were found in this study.
Journal ArticleDOI
Clinical Evaluation of QuickNaviTM-Ebola in the 2018 Outbreak of Ebola Virus Disease in the Democratic Republic of the Congo.
Sheila Makiala,Daniel Mukadi,Anja De Weggheleire,Shino Muramatsu,Kato Daisuke,Koichi Inano,Fumio Gondaira,Masahiro Kajihara,Reiko Yoshida,Katendi Changula,Aaron S. Mweene,Placide Mbala-Kingebeni,Jean-Jacques Muyembe-Tamfum,Justin Masumu,Steve Ahuka,Ayato Takada +15 more
TL;DR: Results indicate the practical reliability of QuickNaviTM-Ebola for point-of-care diagnosis of EVD and compare it to GeneXpert-confirmed cases, respectively.